ABT three-lens brief
Evidence-based stock research on ABT. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Outperforming SPY by 9.7pp over 30 days. · Earnings in 5 days (2026-07-16).
- Outperforming SPY by 9.7pp over 30 days.
- Analyst mean target $116.40 — 23% above current (25 analysts).
- Earnings in 5 days (2026-07-16).
- Ex-dividend date 2026-07-15.
ABT closed at $94.30 (-0.11%) as of 2026-07-10. Market cap: $164.25B. P/E (trailing) 26.4. Price is above the 50-day MA and below the 200-day MA. Positives: outperforming SPY by 9.7pp over 30 days.; analyst mean target $116.40 — 23% above current (25 analysts).. Concerns: earnings in 5 days (2026-07-16).. Last quarter: Revenue $11.16B, net income $1.08B, free cash flow $6.34B. Watching for: 2026-07-16 earnings release (5 days out).
Why three lenses on ABT, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ABTacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ABT" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ABT brief"></iframe>